GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Outperform
MDT
up 94.80 %

Medtronic, Inc. (MDT) rated Outperform with price target $57 by Oppenheimer

Posted on: Wednesday,  May 22, 2013  9:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Medtronic, Inc. (NYSE: MDT) on 05/22/2013. Previously Oppenheimer rated Outperform Medtronic, Inc. (NYSE: MDT) on 07/14/2010., when
the stock price was $37.74. Since then, Medtronic, Inc. has gained 94.81% as of 08/27/2015's recent price of $73.52.
If you would have followed the previous Oppenheimer's recommendation on MDT, you would have gained 94.8% of your investment in 1870 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/22/2013 9:25 AM Buy
None
52.21 57.00
as of 12/13/2013
1 Week down  -3.86 %
1 Month down  -3.95 %
3 Months up  4.31 %
1 YTD up  36.25 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2013 9:25 AM Buy
None
46.89 52.00
5/9/2011 8:25 AM Buy
None
42.45 48.00
8/25/2010 8:25 AM Buy
None
31.14 42.00
7/14/2010 8:25 AM Buy
None
37.74 48.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy